{"transactions":[{"id":3562011,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":158498,"kind":"person","name":"Ratliff John D","position":1,"cik":"0001575951","reported_name":"Ratliff John D","relationship":{"officer":true,"officer_title":"CEO, Covance Drug Development"}}],"security":"Restricted Stock Unit","published_at":"2019-04-05T16:01:32.000Z","date":"2019-04-03","kind":"exercise","acquired":false,"shares":2424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Restricted Stock Units vest in three installments as follows: 20% of the Restricted Stock Units vested on April 3, 2019; 30% of the Restricted Stock Units will vest on April 3, 2020; and 50% of the Restricted Stock Units will vest on April 3, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Restricted Stock Units vest in three installments as follows: 20% of the Restricted Stock Units vested on April 3, 2019; 30% of the Restricted Stock Units will vest on April 3, 2020; and 50% of the Restricted Stock Units will vest on April 3, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":19787,"derivative":{"underlying":"Common Stock","underlying_shares":2424},"source":{"system":"sec-edgar","filing":"0001127602-19-014865","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760219014865/form4.xml","form_type":"4"}},{"id":3562010,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":158498,"kind":"person","name":"Ratliff John D","position":1,"cik":"0001575951","reported_name":"Ratliff John D","relationship":{"officer":true,"officer_title":"CEO, Covance Drug Development"}}],"security":"Common Stock","published_at":"2019-04-05T16:01:32.000Z","date":"2019-04-03","kind":"tax_withholding","acquired":false,"shares":1084,"price":156.68,"value":169841.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":16941,"source":{"system":"sec-edgar","filing":"0001127602-19-014865","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760219014865/form4.xml","form_type":"4"}},{"id":3562009,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":158498,"kind":"person","name":"Ratliff John D","position":1,"cik":"0001575951","reported_name":"Ratliff John D","relationship":{"officer":true,"officer_title":"CEO, Covance Drug Development"}}],"security":"Common Stock","published_at":"2019-04-05T16:01:32.000Z","date":"2019-04-03","kind":"exercise","acquired":true,"shares":2424,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."}],"balance_after":18025,"source":{"system":"sec-edgar","filing":"0001127602-19-014865","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760219014865/form4.xml","form_type":"4"}},{"id":3657873,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":158498,"kind":"person","name":"Ratliff John D","position":1,"cik":"0001575951","reported_name":"Ratliff John D","relationship":{"officer":true,"officer_title":"CEO, Covance Drug Development"}}],"security":"Non-qualified Stock Options","published_at":"2019-02-14T21:08:04.000Z","date":"2019-02-12","kind":"grant","acquired":true,"shares":21800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option vests in three equal installments beginning on the date reflected in this column."}],"balance_after":21800,"derivative":{"exercise_price":146.59,"exercise_date":"2020-02-12","expiration_date":"2029-02-11","underlying":"Common Stock","underlying_shares":21800},"source":{"system":"sec-edgar","filing":"0001127602-19-005984","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760219005984/form4.xml","form_type":"4"}},{"id":3657872,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":158498,"kind":"person","name":"Ratliff John D","position":1,"cik":"0001575951","reported_name":"Ratliff John D","relationship":{"officer":true,"officer_title":"CEO, Covance Drug Development"}}],"security":"Restricted Stock Unit","published_at":"2019-02-14T21:08:04.000Z","date":"2019-02-12","kind":"grant","acquired":true,"shares":5300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Restricted Stock Units vest in three equal annual installments beginning on 2/12/2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Restricted Stock Units vest in three equal annual installments beginning on 2/12/2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":22211,"derivative":{"underlying":"Common Stock","underlying_shares":5300},"source":{"system":"sec-edgar","filing":"0001127602-19-005984","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760219005984/form4.xml","form_type":"4"}},{"id":3657871,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":158498,"kind":"person","name":"Ratliff John D","position":1,"cik":"0001575951","reported_name":"Ratliff John D","relationship":{"officer":true,"officer_title":"CEO, Covance Drug Development"}}],"security":"Restricted Stock Unit","published_at":"2019-02-14T21:08:04.000Z","date":"2019-02-12","kind":"exercise","acquired":false,"shares":1463,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/12/19."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/12/19."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":16911,"derivative":{"underlying":"Common Stock","underlying_shares":1463},"source":{"system":"sec-edgar","filing":"0001127602-19-005984","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760219005984/form4.xml","form_type":"4"}},{"id":3657870,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":158498,"kind":"person","name":"Ratliff John D","position":1,"cik":"0001575951","reported_name":"Ratliff John D","relationship":{"officer":true,"officer_title":"CEO, Covance Drug Development"}}],"security":"Common Stock","published_at":"2019-02-14T21:08:04.000Z","date":"2019-02-12","kind":"tax_withholding","acquired":false,"shares":654,"price":146.59,"value":95869.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":15601,"source":{"system":"sec-edgar","filing":"0001127602-19-005984","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760219005984/form4.xml","form_type":"4"}},{"id":3657869,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":158498,"kind":"person","name":"Ratliff John D","position":1,"cik":"0001575951","reported_name":"Ratliff John D","relationship":{"officer":true,"officer_title":"CEO, Covance Drug Development"}}],"security":"Common Stock","published_at":"2019-02-14T21:08:04.000Z","date":"2019-02-12","kind":"exercise","acquired":true,"shares":1463,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."}],"balance_after":16255,"source":{"system":"sec-edgar","filing":"0001127602-19-005984","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760219005984/form4.xml","form_type":"4"}},{"id":3661302,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":158498,"kind":"person","name":"Ratliff John D","position":1,"cik":"0001575951","reported_name":"Ratliff John D","relationship":{"officer":true,"officer_title":"CEO, Covance Drug Development"}}],"security":"Restricted Stock Unit","published_at":"2019-02-13T16:55:17.000Z","date":"2019-02-11","kind":"exercise","acquired":false,"shares":6100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Restricted Stock Units vested in three equal annual installments beginning on 2/9/17 and are now fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Restricted Stock Units vested in three equal annual installments beginning on 2/9/17 and are now fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":18374,"derivative":{"underlying":"Common Stock","underlying_shares":6100},"source":{"system":"sec-edgar","filing":"0001127602-19-005556","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760219005556/form4.xml","form_type":"4"}},{"id":3661301,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":158498,"kind":"person","name":"Ratliff John D","position":1,"cik":"0001575951","reported_name":"Ratliff John D","relationship":{"officer":true,"officer_title":"CEO, Covance Drug Development"}}],"security":"Common Stock","published_at":"2019-02-13T16:55:17.000Z","date":"2019-02-11","kind":"tax_withholding","acquired":false,"shares":1973,"price":144.29,"value":284684.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":14792,"source":{"system":"sec-edgar","filing":"0001127602-19-005556","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760219005556/form4.xml","form_type":"4"}},{"id":3661300,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":158498,"kind":"person","name":"Ratliff John D","position":1,"cik":"0001575951","reported_name":"Ratliff John D","relationship":{"officer":true,"officer_title":"CEO, Covance Drug Development"}}],"security":"Common Stock","published_at":"2019-02-13T16:55:17.000Z","date":"2019-02-11","kind":"exercise","acquired":true,"shares":6100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."}],"balance_after":16765,"source":{"system":"sec-edgar","filing":"0001127602-19-005556","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760219005556/form4.xml","form_type":"4"}},{"id":3666548,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":158498,"kind":"person","name":"Ratliff John D","position":1,"cik":"0001575951","reported_name":"Ratliff John D","relationship":{"officer":true,"officer_title":"CEO, Covance Drug Development"}}],"security":"Restricted Stock Unit","published_at":"2019-02-12T00:59:28.000Z","date":"2019-02-07","kind":"exercise","acquired":false,"shares":1863,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/7/18."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/7/18."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":24474,"derivative":{"underlying":"Common Stock","underlying_shares":1863},"source":{"system":"sec-edgar","filing":"0001127602-19-005195","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760219005195/form4.xml","form_type":"4"}},{"id":3666547,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":158498,"kind":"person","name":"Ratliff John D","position":1,"cik":"0001575951","reported_name":"Ratliff John D","relationship":{"officer":true,"officer_title":"CEO, Covance Drug Development"}}],"security":"Common Stock","published_at":"2019-02-12T00:59:28.000Z","date":"2019-02-07","kind":"tax_withholding","acquired":false,"shares":556,"price":147.46,"value":81987.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":10665,"source":{"system":"sec-edgar","filing":"0001127602-19-005195","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760219005195/form4.xml","form_type":"4"}},{"id":3666546,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":158498,"kind":"person","name":"Ratliff John D","position":1,"cik":"0001575951","reported_name":"Ratliff John D","relationship":{"officer":true,"officer_title":"CEO, Covance Drug Development"}}],"security":"Common Stock","published_at":"2019-02-12T00:59:28.000Z","date":"2019-02-07","kind":"exercise","acquired":true,"shares":1863,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."}],"balance_after":11261,"source":{"system":"sec-edgar","filing":"0001127602-19-005195","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760219005195/form4.xml","form_type":"4"}},{"id":3968786,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":158498,"kind":"person","name":"Ratliff John D","position":1,"cik":"0001575951","reported_name":"Ratliff John D","relationship":{"officer":true,"officer_title":"CEO, Covance Drug Development"}}],"security":"Restricted Stock Unit","published_at":"2018-04-05T14:14:03.000Z","date":"2018-04-03","kind":"grant","acquired":true,"shares":12120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Stock Units will vest in three installments as follows: 20% of the Restricted Stock Units will vest on April 3, 2019; 30% of the Restricted Stock Units will vest on April 3, 2020; and 50% of the Restricted Stock Units will vest on April 3, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Stock Units will vest in three installments as follows: 20% of the Restricted Stock Units will vest on April 3, 2019; 30% of the Restricted Stock Units will vest on April 3, 2020; and 50% of the Restricted Stock Units will vest on April 3, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":26337,"derivative":{"underlying":"Common Stock","underlying_shares":12120},"source":{"system":"sec-edgar","filing":"0001127602-18-014165","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760218014165/form4.xml","form_type":"4"}},{"id":4060326,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":158498,"kind":"person","name":"Ratliff John D","position":1,"cik":"0001575951","reported_name":"Ratliff John D","relationship":{"officer":true,"officer_title":"CEO, Covance Drug Development"}}],"security":"Restricted Stock Unit","published_at":"2018-02-14T19:25:43.000Z","date":"2018-02-12","kind":"grant","acquired":true,"shares":4390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Restricted Stock Units vest in three equal annual installments beginning on 2/12/19."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Restricted Stock Units vest in three equal annual installments beginning on 2/12/19."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":14217,"derivative":{"underlying":"Common Stock","underlying_shares":4390},"source":{"system":"sec-edgar","filing":"0001127602-18-005993","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760218005993/form4.xml","form_type":"4"}},{"id":4060325,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":158498,"kind":"person","name":"Ratliff John D","position":1,"cik":"0001575951","reported_name":"Ratliff John D","relationship":{"officer":true,"officer_title":"CEO, Covance Drug Development"}}],"security":"Non-qualified Stock Options","published_at":"2018-02-14T19:25:43.000Z","date":"2018-02-12","kind":"grant","acquired":true,"shares":17100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in three equal installments beginning on the date reflected in this column."}],"balance_after":17100,"derivative":{"exercise_price":168.49,"exercise_date":"2019-02-12","expiration_date":"2028-02-11","underlying":"Common Stock","underlying_shares":17100},"source":{"system":"sec-edgar","filing":"0001127602-18-005993","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760218005993/form4.xml","form_type":"4"}},{"id":4063992,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":158498,"kind":"person","name":"Ratliff John D","position":1,"cik":"0001575951","reported_name":"Ratliff John D","relationship":{"officer":true,"officer_title":"CEO, Covance Drug Development"}}],"security":"Restricted Stock Unit","published_at":"2018-02-13T19:08:16.000Z","date":"2018-02-09","kind":"exercise","acquired":false,"shares":6100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Restricted Stock Units vest in three equal annual installments beginning on 2/9/2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Restricted Stock Units vest in three equal annual installments beginning on 2/9/2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":9827,"derivative":{"underlying":"Common Stock","underlying_shares":6100},"source":{"system":"sec-edgar","filing":"0001127602-18-005415","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760218005415/form4.xml","form_type":"4"}},{"id":4063991,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":158498,"kind":"person","name":"Ratliff John D","position":1,"cik":"0001575951","reported_name":"Ratliff John D","relationship":{"officer":true,"officer_title":"CEO, Covance Drug Development"}}],"security":"Common Stock","published_at":"2018-02-13T19:08:16.000Z","date":"2018-02-09","kind":"tax_withholding","acquired":false,"shares":2132,"price":168.08,"value":358346.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":9398,"source":{"system":"sec-edgar","filing":"0001127602-18-005415","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760218005415/form4.xml","form_type":"4"}},{"id":4063990,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":158498,"kind":"person","name":"Ratliff John D","position":1,"cik":"0001575951","reported_name":"Ratliff John D","relationship":{"officer":true,"officer_title":"CEO, Covance Drug Development"}}],"security":"Common Stock","published_at":"2018-02-13T19:08:16.000Z","date":"2018-02-09","kind":"exercise","acquired":true,"shares":6100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."}],"balance_after":11530,"source":{"system":"sec-edgar","filing":"0001127602-18-005415","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760218005415/form4.xml","form_type":"4"}},{"id":4069179,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":158498,"kind":"person","name":"Ratliff John D","position":1,"cik":"0001575951","reported_name":"Ratliff John D","relationship":{"officer":true,"officer_title":"CEO, Covance Drug Development"}}],"security":"Restricted Stock Unit","published_at":"2018-02-09T21:11:47.000Z","date":"2018-02-07","kind":"exercise","acquired":false,"shares":1863,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Restricted Stock Units vest in three equal annual installments beginning on 2/7/18."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Restricted Stock Units vest in three equal annual installments beginning on 2/7/18."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":15927,"derivative":{"underlying":"Common Stock","underlying_shares":1863},"source":{"system":"sec-edgar","filing":"0001127602-18-004915","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760218004915/form4.xml","form_type":"4"}},{"id":4069178,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":158498,"kind":"person","name":"Ratliff John D","position":1,"cik":"0001575951","reported_name":"Ratliff John D","relationship":{"officer":true,"officer_title":"CEO, Covance Drug Development"}}],"security":"Common Stock","published_at":"2018-02-09T21:11:47.000Z","date":"2018-02-07","kind":"tax_withholding","acquired":false,"shares":560,"price":169.66,"value":95009.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":5430,"source":{"system":"sec-edgar","filing":"0001127602-18-004915","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760218004915/form4.xml","form_type":"4"}},{"id":4069177,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":158498,"kind":"person","name":"Ratliff John D","position":1,"cik":"0001575951","reported_name":"Ratliff John D","relationship":{"officer":true,"officer_title":"CEO, Covance Drug Development"}}],"security":"Common Stock","published_at":"2018-02-09T21:11:47.000Z","date":"2018-02-07","kind":"exercise","acquired":true,"shares":1863,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."}],"balance_after":5990,"source":{"system":"sec-edgar","filing":"0001127602-18-004915","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760218004915/form4.xml","form_type":"4"}},{"id":4454961,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":158498,"kind":"person","name":"Ratliff John D","position":1,"cik":"0001575951","reported_name":"Ratliff John D","relationship":{"officer":true,"officer_title":"CEO, Covance Drug Development"}}],"security":"Restricted Stock Unit","published_at":"2017-02-13T19:28:16.000Z","date":"2017-02-09","kind":"exercise","acquired":false,"shares":6100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Restricted Stock Units vest in three equal annual installments beginning on 2/9/17."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Restricted Stock Units vest in three equal annual installments beginning on 2/9/17."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":17790,"derivative":{"underlying":"Common Stock","underlying_shares":6100},"source":{"system":"sec-edgar","filing":"0001127602-17-005326","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760217005326/form4.xml","form_type":"4"}},{"id":4454960,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":158498,"kind":"person","name":"Ratliff John D","position":1,"cik":"0001575951","reported_name":"Ratliff John D","relationship":{"officer":true,"officer_title":"CEO, Covance Drug Development"}}],"security":"Common Stock","published_at":"2017-02-13T19:28:16.000Z","date":"2017-02-09","kind":"tax_withholding","acquired":false,"shares":2013,"price":133.83,"value":269399.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":4127,"source":{"system":"sec-edgar","filing":"0001127602-17-005326","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760217005326/form4.xml","form_type":"4"}},{"id":4454959,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":158498,"kind":"person","name":"Ratliff John D","position":1,"cik":"0001575951","reported_name":"Ratliff John D","relationship":{"officer":true,"officer_title":"CEO, Covance Drug Development"}}],"security":"Common Stock","published_at":"2017-02-13T19:28:16.000Z","date":"2017-02-09","kind":"exercise","acquired":true,"shares":6100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."}],"balance_after":6140,"source":{"system":"sec-edgar","filing":"0001127602-17-005326","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760217005326/form4.xml","form_type":"4"}},{"id":4460129,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":158498,"kind":"person","name":"Ratliff John D","position":1,"cik":"0001575951","reported_name":"Ratliff John D","relationship":{"officer":true,"officer_title":"CEO, Covance Drug Development"}}],"security":"Non-qualified Stock Options","published_at":"2017-02-09T19:44:34.000Z","date":"2017-02-07","kind":"grant","acquired":true,"shares":21300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests in three equal installments beginning on the date reflected in this column."}],"balance_after":21300,"derivative":{"exercise_price":130.6,"exercise_date":"2018-02-07","expiration_date":"2027-02-06","underlying":"Common Stock","underlying_shares":21300},"source":{"system":"sec-edgar","filing":"0001127602-17-004733","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760217004733/form4.xml","form_type":"4"}},{"id":4460128,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":158498,"kind":"person","name":"Ratliff John D","position":1,"cik":"0001575951","reported_name":"Ratliff John D","relationship":{"officer":true,"officer_title":"CEO, Covance Drug Development"}}],"security":"Restricted Stock Unit","published_at":"2017-02-09T19:44:34.000Z","date":"2017-02-07","kind":"grant","acquired":true,"shares":5590,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Stock Units vest in three equal annual installments beginning on 2/7/18."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Stock Units vest in three equal annual installments beginning on 2/7/18."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":23890,"derivative":{"underlying":"Common Stock","underlying_shares":5590},"source":{"system":"sec-edgar","filing":"0001127602-17-004733","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760217004733/form4.xml","form_type":"4"}},{"id":4585207,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":158498,"kind":"person","name":"Ratliff John D","position":1,"cik":"0001575951","reported_name":"Ratliff John D","relationship":{"officer":true,"officer_title":"CEO, Covance Drug Development"}}],"security":"Restricted Stock Unit","published_at":"2016-10-05T19:57:58.000Z","date":"2016-10-03","kind":"grant","acquired":true,"shares":18300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Stock Units vest in three equal annual installments beginning on 2/9/17."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Stock Units vest in three equal annual installments beginning on 2/9/17."}],"balance_after":18300,"derivative":{"underlying":"Common Stock","underlying_shares":18300},"source":{"system":"sec-edgar","filing":"0001127602-16-064300","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760216064300/form4.xml","form_type":"4"}}]}